Vaxart (VXRT) Competitors

Vaxart (NASDAQ:VXRT) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends.

Do institutionals and insiders hold more shares of VXRT or INO?

18.1% of Vaxart shares are held by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. 2.6% of Vaxart shares are held by insiders. Comparatively, 2.5% of Inovio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in VXRT or INO?

Inovio Pharmaceuticals received 408 more outperform votes than Vaxart when rated by MarketBeat users. Likewise, 71.30% of users gave Inovio Pharmaceuticals an outperform vote while only 65.54% of users gave Vaxart an outperform vote.

Company	Underperform	Outperform
Vaxart	Outperform Votes 310 65.54%	Underperform Votes 163 34.46%
Inovio Pharmaceuticals	Outperform Votes 718 71.30%	Underperform Votes 289 28.70%

Does the media refer more to VXRT or INO?

In the previous week, Inovio Pharmaceuticals had 2 more articles in the media than Vaxart. MarketBeat recorded 6 mentions for Inovio Pharmaceuticals and 4 mentions for Vaxart. Vaxart's average media sentiment score of 0.66 beat Inovio Pharmaceuticals' score of 0.38 indicating that Vaxart is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vaxart	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inovio Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend VXRT or INO?

Vaxart presently has a consensus target price of $3.00, suggesting a potential upside of 315.40%. Inovio Pharmaceuticals has a consensus target price of $43.80, suggesting a potential upside of 750.49%. Given Inovio Pharmaceuticals' higher probable upside, analysts plainly believe Inovio Pharmaceuticals is more favorable than Vaxart.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vaxart	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inovio Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Is VXRT or INO more profitable?

Inovio Pharmaceuticals has a net margin of 0.00% compared to Vaxart's net margin of -543.21%. Inovio Pharmaceuticals' return on equity of -99.51% beat Vaxart's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vaxart	-543.21%	-114.19%	-75.68%
Inovio Pharmaceuticals	N/A	-99.51%	-70.90%

Which has more volatility & risk, VXRT or INO?

Vaxart has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Which has preferable earnings and valuation, VXRT or INO?

Vaxart has higher revenue and earnings than Inovio Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vaxart	$7.38M	17.36	-$82.46M	-$0.46	-1.57
Inovio Pharmaceuticals	$591.86K	225.92	-$135.12M	N/A	N/A

Summary

Inovio Pharmaceuticals beats Vaxart on 11 of the 16 factors compared between the two stocks.